Evidence map›Paper›PMID 37347435›Full record

ReviewMolecular biotechnology2026

Nanostructured Materials for Drug Delivery and Tissue Engineering Applications.

Antonela Matić, Emina Karahmet Sher, Esma Karahmet Farhat, Farooq Sher

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Antonela MatićFaculty of Pharmacy, University of Modern Sciences - CKM, Mostar, 88000, Bosnia and Herzegovina.
Emina Karahmet SherDepartment of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK. Emina.Sher@isest.org.
Esma Karahmet FarhatDepartment of Food and Nutrition Research, Faculty of Food and Technology, Josip Juraj Strossmayer University of Osijek, Osijek, 31000, Croatia.
Farooq SherDepartment of Engineering, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK. Farooq.Sher@ntu.ac.uk.ORCID http://orcid.org/0000-0003-2890-5912
Nottingham Trent University · GBUniversity of Mostar · BAUniversity of Osijek · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology and nanostructured materials for drug delivery and tissue engineering applications are relatively new field that is constantly advancing and expanding. The materials used are at the nanoscale level. Recently, great discoveries and applications have been made (Agents for use in chemotherapy, biological agents and immunotherapy agents) in the treatment of diseases in various areas. Tissue engineering is based on the regeneration and repair of damaged organs and tissues by developing biological substitutes that restore, maintain or improve the function of tissues and organs. Cells isolated from patients are used to seed 3D nanoparticles that can be synthetic or natural biomaterials. For the development of new tissue in tissue engineering, it is necessary to meet the conditions for connecting cells. This paper will present the ways of connecting cells and creating new tissues. Some recent discoveries and advances in the field of nanomedicine and the application of nanotechnology in drug delivery will be presented. Furthermore, the improvement of the effectiveness of new and old drugs based on the application of nanotechnology will be shown.

Indexed as

Biocompatible MaterialsDrug Delivery SystemsNanostructuresTissue EngineeringAnimalsHumansNanomedicineNanotechnologyBiocompatible MaterialsControlled drug deliveryNanomedicineNanoparticlesNanostructured materialsTissue engineering

Identifiers

PMID37347435
PMCPMC13558372
OpenAlexW4381598126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.